|
Pharmacokinetics of Isavuconazole in Liver Impairment due to Hepatitis (click for details) |
|
|
|
Genome Plasticity in Cryptococcus neoformans, a Human Pathogen, Contributes to Adaptive Azole Resistance (click for details) |
|
|
|
Fungal Rhinosinusitis (click for details) |
|
|
|
Prognostic Features of Galactomannan (GM) in GM-Positive Invasive Aspergillosis (GPA) (click for details) |
|
|
|
Eumycetoma, Phaeohyphomycoses and Chromomycosis (click for details) |
|
|
|
Susceptibility Profiles of Sequence Identified Clinical Aspergillus Isolates in South-East Europe (click for details) |
|
|
|
Time- and Concentration-Dependent Pharmacodynamic Characteristics of Amphotericin B (AMB), Voriconazole (VOR) and Caspofungin (CAS) against Aspergillus fumigatus (AF) Conidia and Hyphae Using Growth Curve Analysis (click for details) |
|
|
|
Con: Antifungal Prophylaxis for Neonatal Candidiasis (click for details) |
|
|
|
Risk of Opportunistic Infections on Tumor Necrosis Factor: 945; Blockers: A Case-Control Analysis from the French 3 -Year Prospective RATIO Registry (click for details) |
|
|
|
In Vitro & Ex Vivo Activity of NP213, a Fungicidal Peptide for the Treatment of Onychomycosis (click for details) |
|
|
